Variant report
Variant | nsv968350 |
---|---|
Chromosome Location | chr5:177206188-177210315 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:183)
- Chromatin interactive region (count:0)
- LncRNA region (count:8)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CBX3 | chr5:177209512-177209875 | K562 | blood: | n/a | n/a |
2 | CBX3 | chr5:177209565-177209833 | K562 | blood: | n/a | n/a |
3 | CTCF | chr5:177210068-177210100 | Spleen_OC | spleen: | n/a | n/a |
4 | CTCF | chr5:177208101-177208143 | GM13976 | blood: | n/a | n/a |
5 | CTCF | chr5:177209214-177209253 | Lung_OC | lung: | n/a | n/a |
6 | EBF1 | chr5:177209877-177210244 | GM12878 | blood: | n/a | n/a |
7 | PBX3 | chr5:177206184-177206372 | GM12878 | blood: | n/a | n/a |
8 | POLR2A | chr5:177209980-177210245 | A549 | lung: | n/a | n/a |
9 | POLR2A | chr5:177209861-177210101 | A549 | lung: | n/a | n/a |
10 | POLR2A | chr5:177209940-177210220 | A549 | lung: | n/a | n/a |
11 | POLR2A | chr5:177209943-177210280 | A549 | lung: | n/a | n/a |
12 | TCF3 | chr5:177209790-177210059 | GM12878 | blood: | n/a | chr5:177209862-177209878 |
13 | ZBTB33 | chr5:177209560-177209809 | K562 | blood: | n/a | n/a |
14 | ZBTB33 | chr5:177209478-177209959 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:177209285-177209335 | K562 | blood: | n/a |
2 | chr5:177209947-177209997 | ProgFib | skin: | n/a |
3 | chr5:177209285-177209335 | MCF-7 | breast: | n/a |
4 | chr5:177210257-177210307 | A549 | lung: | n/a |
5 | chr5:177209947-177209997 | AG09309 | skin: | n/a |
6 | chr5:177209947-177209997 | HEK293 | kidney: | embryo |
7 | chr5:177210257-177210307 | AG09319 | gingival: | n/a |
8 | chr5:177209285-177209335 | HEK293 | kidney: | embryo |
9 | chr5:177209285-177209335 | SK-N-MC | brain: | n/a |
10 | chr5:177209285-177209335 | HNPCEpiC | eye: | n/a |
11 | chr5:177209285-177209335 | BJ | skin: | n/a |
12 | chr5:177209947-177209997 | NHBE | bronchial: | n/a |
13 | chr5:177209285-177209335 | GM12891 | blood: | n/a |
14 | chr5:177210257-177210307 | Hepatocyte | liver: | n/a |
15 | chr5:177209947-177209997 | HCF | heart: | n/a |
16 | chr5:177209947-177209997 | BE2_C | brain: | n/a |
17 | chr5:177210257-177210307 | HRPEpiC | eye: | n/a |
18 | chr5:177209285-177209335 | GM06990 | blood: | n/a |
19 | chr5:177209285-177209335 | HepG2 | liver: | n/a |
20 | chr5:177209285-177209335 | ProgFib | skin: | n/a |
21 | chr5:177209947-177209997 | NHDF-neo | bronchial: | n/a |
22 | chr5:177210257-177210307 | AG04450 | lung: | fetal |
23 | chr5:177209285-177209335 | NT2-D1 | testis: | n/a |
24 | chr5:177209947-177209997 | HepG2 | liver: | n/a |
25 | chr5:177210257-177210307 | SKMC | muscle: | n/a |
26 | chr5:177210257-177210307 | LNCaP | prostate: | n/a |
27 | chr5:177210257-177210307 | HIPEpiC | eye: | n/a |
28 | chr5:177209947-177209997 | SK-N-MC | brain: | n/a |
29 | chr5:177209285-177209335 | GM12892 | blood: | n/a |
30 | chr5:177209285-177209335 | CMK | blood: | n/a |
31 | chr5:177209947-177209997 | HCM | heart: | n/a |
32 | chr5:177210257-177210307 | HCT-116 | colon: | n/a |
33 | chr5:177209947-177209997 | HRE | kidney: | n/a |
34 | chr5:177209947-177209997 | SAEC | small airway: | n/a |
35 | chr5:177209947-177209997 | GM12892 | blood: | n/a |
36 | chr5:177209285-177209335 | HIPEpiC | eye: | n/a |
37 | chr5:177209947-177209997 | HPAEpiC | pulmonary alveolar: | n/a |
38 | chr5:177209285-177209335 | MCF10A-Er-Src | breast: | n/a |
39 | chr5:177209947-177209997 | HAEpiC | amniotic membrane: | n/a |
40 | chr5:177210257-177210307 | HRCEpiC | kidney: | n/a |
41 | chr5:177209285-177209335 | U87 | brain: | n/a |
42 | chr5:177209285-177209335 | A549 | lung: | n/a |
43 | chr5:177210257-177210307 | ovcar-3 | ovarian: | n/a |
44 | chr5:177209947-177209997 | CMK | blood: | n/a |
45 | chr5:177210257-177210307 | HNPCEpiC | eye: | n/a |
46 | chr5:177209285-177209335 | Caco-2 | colon: | n/a |
47 | chr5:177209285-177209335 | NH-A | brain: | n/a |
48 | chr5:177209947-177209997 | SK-N-SH | brain: | n/a |
49 | chr5:177210257-177210307 | NT2-D1 | testis: | n/a |
50 | chr5:177210257-177210307 | PrEC | prostate: | n/a |
No data |
(count:8 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAM193B-7 | chr5:177206498-177206718 | NONHSAT105467 |
2 | lnc-FAM193B-7 | chr5:177207450-177207505 | NONHSAT105465 |
3 | lnc-FAM193B-7 | chr5:177207450-177207505 | NONHSAT105467 |
4 | lnc-FAM193B-7 | chr5:177209744-177209814 | NONHSAT105468 |
5 | lnc-FAM193B-7 | chr5:177208586-177208685 | NONHSAT105467 |
6 | lnc-FAM193B-7 | chr5:177207450-177207505 | NONHSAT105468 |
7 | lnc-FAM193B-7 | chr5:177206557-177206718 | NONHSAT105468 |
8 | lnc-FAM193B-7 | chr5:177210285-177210365 | NONHSAT105465 |
No data |
No data |
Variant related genes | Relation type |
---|---|
FAM153A | TF binding region |
ENSG00000249109 | TF binding region |
FAM153A | CpG island |
ENSG00000249109 | CpG island |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7378862 | chr5:177206205-177206206 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
2 | rs548243758 | chr5:177206271-177206272 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs375854522 | chr5:177206285-177206286 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs369066147 | chr5:177206290-177206291 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs35016924 | chr5:177206291-177206292 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs199984889 | chr5:177206292-177206293 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs181910081 | chr5:177206309-177206310 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs201560125 | chr5:177206627-177206628 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs62399974 | chr5:177206712-177206713 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs62399975 | chr5:177206714-177206715 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs572922280 | chr5:177209038-177209039 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540197868 | chr5:177209053-177209054 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs377646207 | chr5:177209097-177209098 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs565044983 | chr5:177209114-177209115 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191273776 | chr5:177209254-177209255 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376066678 | chr5:177209321-177209322 | Active TSS | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs532638292 | chr5:177209323-177209324 | Active TSS | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs550936410 | chr5:177209350-177209351 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs28450227 | chr5:177209382-177209383 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs530356456 | chr5:177209431-177209432 | Active TSS Enhancers Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs62399978 | chr5:177209510-177209511 | Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs28588700 | chr5:177209585-177209586 | Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs75196305 | chr5:177209661-177209662 | Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs111419142 | chr5:177209662-177209663 | Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs79321202 | chr5:177209671-177209672 | Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs28594523 | chr5:177209681-177209682 | Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs200447169 | chr5:177209689-177209690 | Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs28624801 | chr5:177209700-177209701 | Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs181125595 | chr5:177209777-177209778 | Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs371953256 | chr5:177209787-177209788 | Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs375396375 | chr5:177209824-177209825 | Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs375550869 | chr5:177209902-177209903 | Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs548923138 | chr5:177210186-177210187 | Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs567135885 | chr5:177210198-177210199 | Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs186642627 | chr5:177210219-177210220 | Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs191446343 | chr5:177210229-177210230 | Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs183187198 | chr5:177210233-177210234 | Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs527281021 | chr5:177210239-177210240 | Active TSS Bivalent/Poised TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs187861779 | chr5:177210269-177210270 | Active TSS Bivalent/Poised TSS | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
epilepsy | 18472482 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Sotos syndrome | 21572526 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Sotos syndrome | 17561922 | CNVD |
Sotos syndrome | 16773131 | CNVD |
Mental retardation | 16773131 | CNVD |
Sotos syndrome | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Lung cancer | 17297452 | CNVD |
Cancer | 20164920 | CNVD |
Autism | 20841430 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sotos syndrome | 22283845 | CNVD |
Breast cancer | 16272173 | CNVD |
Sotos syndrome | 20503325 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 19181860 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ehlers-danlos syndrome | 17576883 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19246517 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Ependymoma | 20639864 | CNVD |
Non-syndromic sensorineural hearing loss | 19212409 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:177209000-177209800 | Active TSS | Primary T helper cells PMA-I stimulated | -- |
2 | chr5:177209400-177209600 | Enhancers | Primary T cells effector/memory enriched fromperipheralblood | blood |
3 | chr5:177209400-177209600 | Enhancers | Pancreas | Pancrea |
4 | chr5:177209400-177209800 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
5 | chr5:177209400-177209800 | Bivalent/Poised TSS | Fetal Adrenal Gland | Adrenal Gland |
6 | chr5:177209400-177210200 | Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr5:177209400-177210400 | Active TSS | Primary T helper naive cells fromperipheralblood | blood |
8 | chr5:177209400-177210400 | Active TSS | Primary T regulatory cells fromperipheralblood | blood |
9 | chr5:177209400-177210600 | Active TSS | Ovary | ovary |
10 | chr5:177209600-177209800 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr5:177209600-177209800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
12 | chr5:177209600-177210400 | Active TSS | Primary T cells fromperipheralblood | blood |
13 | chr5:177209800-177210400 | Bivalent/Poised TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr5:177210000-177210400 | Active TSS | Brain Angular Gyrus | brain |
15 | chr5:177210000-177210600 | Bivalent/Poised TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |